RNA sequencing identifies lung cancer lineage and facilitates drug repositioning.

Interestingly, the three immune-related profiles including LINE-1, MHC-II enhancers and immuno-specific eRNAs consistently exhibited a decreasing trend from high to low across the bronchial, squamoid and neuroendocrine clusters ( Fig. 3D ).

also in 47,180 other papers